It is predicted that the growth rate will maintain more than 20% from 2014 to 2018. Huidian Research estimates that the sales scale of cardiovascular drugs in China in 2014 will reach about CNY 22 billion, and the figure will be CNY 45 billion by 2018.
Detailed report at: http://www.reportsandintelligence.com/research-on-china-cardiovascular-drugs-industry-2014-2018-market